SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Concord Biotech - Quaterly Results

11 Nov 2024 Evaluate
The Revenue for the quarter ended  September 2024 of Rs. 3101.81 millions grew by 18.23 % from Rs. 2623.46 millions.A humble growth in net profit of 16.81% reported in the quarter ended September 2024 to Rs. 987.00  millions from Rs. 844.94 millions.Operating profit surged to 1467.04 millions from the corresponding previous quarter of 1273.15 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 3101.81 2623.46 18.23 5259.83 4571.74 15.05 10169.39 8531.68 19.20
Other Income 100.26 81.26 23.38 203.34 147.80 37.58 337.80 353.09 -4.33
PBIDT 1467.04 1273.15 15.23 2382.90 2061.22 15.61 4653.37 3785.96 22.91
Interest 0.96 8.41 -88.59 3.37 15.94 -78.86 25.52 45.10 -43.41
PBDT 1466.08 1264.74 15.92 2379.53 2045.28 16.34 4627.85 3740.86 23.71
Depreciation 133.14 132.95 0.14 264.92 263.36 0.59 535.92 540.32 -0.81
PBT 1332.94 1131.79 17.77 2114.61 1781.92 18.67 4091.93 3200.54 27.85
TAX 345.94 286.85 20.60 545.22 452.27 20.55 1044.62 819.28 27.50
Deferred Tax 5.35 9.29 -42.41 10.69 11.71 -8.71 46.28 23.82 94.29
PAT 987.00 844.94 16.81 1569.39 1329.65 18.03 3047.31 2381.26 27.97
Equity 104.62 104.62 0.00 104.62 104.62 0.00 104.62 104.62 0.00
PBIDTM(%) 47.30 48.53 -2.54 45.30 45.09 0.48 45.76 44.38 3.12

Concord Biotech Share Price

1046.80 -20.60 (-1.93%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×